FilingReader Intelligence

Humanwell Healthcare changes control to China Merchants Group

July 31, 2025 at 05:12 PM UTCBy FilingReader AI

Humanwell Healthcare's controlling shareholder changed to China Merchants Life Science (Wuhan) following a share transfer, with China Merchants Group becoming the de facto controller effective July 30, 2025.

The company appointed Deng Weidong as chairman and Du Wentao as general manager. Humanwell also received approval for its female contraceptive drug, drospirenone and ethinyl estradiol tablets, on July 28, 2025.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Humanwell Healthcare Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →